Search

Your search keyword '"Fiorino, G."' showing total 931 results

Search Constraints

Start Over You searched for: Author "Fiorino, G." Remove constraint Author: "Fiorino, G."
931 results on '"Fiorino, G."'

Search Results

1. Lack of Seroconversion Following COVID-19 Vaccination Is an Independent Risk Factor for SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: Data from ESCAPE-IBD, an IG-IBD Study

2. P298 Adherence to diagnostic and treatment recommendations for the management of acute severe ulcerative colitis: a prospective and multinational study

3. P1141 Global perspectives on managing Inflammatory Bowel Disease (IBD) during pregnancy and lactation: current state and the necessity for enhancements

4. P1177 Perceptions of patients with Inflammatory Bowel Disease and first degree relatives on prediction and prevention of disease

5. DOP03 Gaps between ECCO quality standards of care and the real world: the E-QUALITY survey on processes and outcomes

6. P227 The learning curve for using intestinal ultrasonography

7. P666 Accuracy of information given by ChatGPT for patients with Inflammatory Bowel Disease in relation to ECCO guidelines

8. Safety, hesitancy of coronavirus disease 2019 vaccination and pandemic burden in patients with inflammatory bowel disease: Data of a national study (ESCAPE-IBD)

10. Non-invasive monitoring and treat-to-target approach are cost-effective in patients with mild–moderate ulcerative colitis

11. Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study

12. Safety and clinical efficacy of the double switch from originator infliximab to biosimilars CT-P13 and SB2 in patients with inflammatory bowel diseases (SCESICS): A multicenter cohort study

13. A non-clausal tableau calculus for MINSAT

14. Systematic review and meta-analysis: endoscopic vacuum therapy (evt) versus self-expandable metal stent (sems) for anastomotic leaks after upper gastrointestinal surgery

15. ECCO Guidelines on Inflammatory Bowel Disease and Malignancies.

16. Gut virome-colonising Orthohepadnavirus genus is associated with ulcerative colitis pathogenesis and induces intestinal inflammation in vivo

17. Linear Depth Deduction with Subformula Property for Intuitionistic Epistemic Logic

18. OC.14.2 LACK OF SEROCONVERSION FOLLOWING COVID-19 VACCINATION, BUT NOT TREATMENT, IS AN INDEPENDENT RISK FACTOR FOR BREAKTHROUGH SARS-COV-2 INFECTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA FROM ESCAPE - AN IGIBD STUDY

22. T.08.2 SYSTEMATIC REVIEW AND META-ANALYSIS: ENDOSCOPIC VACUUM THERAPY (EVT) VERSUS SELF-EXPANDABLE METAL STENT (SEMS) FOR ANASTOMOTIC LEAKS AFTER UPPER GASTROINTESTINAL SURGERY

24. OP19 Gaps between ECCO quality standards of care and the real world: the E-QUALITY survey

27. OP32 The gut virome-colonizing Orthohepadnavirus genus is associated with ulcerative colitis pathogenesis and induces intestinal inflammation in vivo

29. P455 Comparison of two strategies for the management of post-operative recurrence in Crohn’s disease patients with one clinical risk factor: a multicentre IG-IBD study

30. P447 Early predictors of the need for surgery in patients with acute severe ulcerative colitis: results of the prospective, observational, international ESCP MASC study

31. LINEE GUIDA EUROEE

32. Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG-IBD LIVE study

33. DOP001 Effectiveness and safety of vedolizumab in anti-TNF naïve patients with inflammatory bowel disease: a multicentre retrospective European Crohn’s and Colitis Organisation study

35. Endoscopic Postoperative Recurrence in Crohn's Disease After Curative Ileocecal Resection with Early Prophylaxis by Anti-TNF, Vedolizumab or Ustekinumab: A Real-World Multicentre European Study.

36. New Tableau Characterizations for Non-clausal MaxSAT Problem

42. P494 Multicentre cohort study to evaluate the need for re-intervention following multimodal treatment in Crohnʼs disease with perianal fistula

44. P366 The efficacy of vedolizumab for induction of clinical response and remission in anti-TNF naïve patients with inflammatory bowel disease – a multicenter European real world experience

46. P240 Presentation and surgical interventions for Crohnʼs disease with perianal fistula in the biologics era: results from a multicentre study

47. P211 Differences in therapeutic approaches and outcomes in paediatric and adult onset Crohnʼs disease with perianal fistula: comparison of 2 multicentre fistula cohorts

49. DOP016 Long-term safety of in utero exposure to anti-tumor necrosis factor for the treatment of inflammatory bowel diseases: results from the multicenter European TEDDY study

Catalog

Books, media, physical & digital resources